You are here

• Home
• Therapy Areas
• Cardiovascular

• Open, Randomized, Phase I Study in Subjects With Type 2 Diabetes Mellitus Treated With Metformin to Evaluate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa

Disease

diabetes type 2

Drug Name

AZD1656

Generic Name

AZD1656

Sponsor

AstraZeneca

Drug Status

Discontinued

Phase

I

Start Date

Feb 18, 2010

Study Name

D1020C00028

Study Id

D1020C00028

ClinicalTrials.gov ID

NCT01082120

Recruiting Status

Closed

Protocol Status

Not Available

Report

Apr 19, 2011

• D1020C00028.pdf (336 KB)

Page tools

• Print
• Bookmark this page